Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers
Thursday, January 05, 2023WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO today announced a license agreement with GSK plc under which GSK will have exclusive licenses for up to four bi multispecific TCE antibodies developed...
Moderna to Acquire OriCiro Genomics
Thursday, January 05, 2023Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and OriCiro Genomics KK a pioneer in cellfree DNA synthesis and amplification technologies today announced they have entered into a definitive agreement throu...
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Wednesday, January 04, 2023Gilead Sciences Inc and EVOQ Therapeutics Inc EVOQ today announced a collaboration and licensing agreement to advance EVOQs proprietary technology for the treatment of rheumatoid arthritis RA and lupus EVOQs NanoDisc technology is designed to enable...
AmerisourceBergen completes acquisition of PharmaLex
Wednesday, January 04, 2023AmerisourceBergen Corporation today announced the completion of its acquisition of PharmaLex Holding GmbH The acquisition of PharmaLex enhances AmerisourceBergens growth strategy by advancing its leadership in specialty services and global platform o...
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Thursday, December 29, 2022Mission Bio the pioneer in highthroughput singlecell DNA and multiomics analysis and Abiosciences the singlecell bioinformatics leader announced a new partnership to codevelop bioinformatics packages for translational and clinical research applicatio...
Opus Genetics Announces Acquisition of the Rights to Two Gene Therapy Product Candidates for Inherited Retinal Diseases
Thursday, December 29, 2022Opus Genetics a patientfirst clinicalstage gene therapy company developing treatments for inherited retinal diseases today announced it has acquired the rights to two preclinicalstage AAVbased gene therapy product candidates for inherited retinal dis...
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
Wednesday, December 28, 2022Kala Pharmaceuticals Inc a clinicalstage biopharmaceutical company dedicated to the research development and commercialization of innovative therapies for rare diseases of the eye today announced that the US Food and Drug Administration FDA has accep...
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
Wednesday, December 28, 2022Gilead Sciences Inc and Jounce Therapeutics Inc amended their existing license agreement for GS formerly JTX enabling Gilead to buy out remaining contingent payments potentially due under the license agreement executed in August As part of the trans...
Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
Tuesday, December 27, 2022Hikma Pharmaceuticals PLC Hikma the multinational pharmaceutical company today announces a new exclusive licensing and commercialization agreement with Junshi Biosciences an innovationdriven biopharmaceutical company for toripalimab in the Middle Eas...
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
Tuesday, December 27, 2022Ablaze Pharmaceuticals announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co Ltd Yonghe to develop series of targeted radiopharmaceutical therapy TRT products Under the agreement Yongh...
